JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shih, N.-Y.
Right arrow Articles by Floyd-Smith, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shih, N.-Y.
Right arrow Articles by Floyd-Smith, G.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 27, Issue of July 5, 1996 pp. 16040-16046
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Protein Kinase C-delta mRNA Is Down-regulated Transcriptionally and Post-transcriptionally by 12-O-Tetradecanoylphorbol-13-acetate

(Received for publication, January 31, 1996, and in revised form, April 1, 1996)

Neng-Yao Shih and Georgia Floyd-Smith

From the Molecular and Cellular Biology Program, Arizona State University, Tempe, Arizona 85287-1501

Activation of protein kinase C-delta (PKC-delta ) by 12-O-tetradecanoylphorbol-13-acetate (TPA) is followed by a gradual decrease in detectable protein 12-24 h later in the mouse B lymphoma cell line A20. Down-regulation is associated with TPA-induced proteolysis and a 50-86% decrease in PKC-delta mRNA 0.5-24 h post-treatment which is due to both a 50% decrease in transcription and accelerated degradation of PKC-delta mRNA as determined using the pulse-chase method. Destabilization of PKC-delta mRNA is also observed when actinomycin D is added to cells pretreated with TPA for 2 h; however, addition of actinomycin D or cycloheximide prior to TPA treatment blocks destabilization. Addition of PKC inhibitors to TPA-treated cells also blocks destabilization of PKC-delta mRNA. Cells treated with TPA for 4 h contain an activity not found in control cells which destabilizes PKC-delta mRNA but not glyceraldehyde-3-phosphate dehydrogenase mRNA in vitro. Addition of TPA to control extracts fails to increase degradation of PKC-delta mRNA in vitro, suggesting that treatment of intact cells is required to induce the synthesis of a factor(s) that destabilizes PKC-delta mRNA. This factor(s) then acts along with transcriptional and post-translational regulatory mechanisms to down-regulate PKC-delta .


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Cell Growth Differ.Home page
R. A. Blake, P. Garcia-Paramio, P. J. Parker, and S. A. Courtneidge
Src Promotes PKC{{delta}} Degradation
Cell Growth Differ., April 1, 1999; 10(4): 231 - 241.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
D. Harris, N. Reiss, and Z. Naor
Differential Activation of Protein Kinase C delta  and epsilon  Gene Expression by Gonadotropin-releasing Hormone in alpha T3-1 Cells. AUTOREGULATION BY PROTEIN KINASE C
J. Biol. Chem., May 23, 1997; 272(21): 13534 - 13540.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.